Upadacitinib an effective treatment option in AD patients with recent discontinuation of dupilumabSeptember 15, 2023Atopic Dermatitis
No association between dupilumab treatment and risk for arthralgia in atopic dermatitisSeptember 15, 2023Atopic Dermatitis
Patients with non-alcoholic fatty liver disease have a lower risk for atopic dermatitis September 15, 2023Atopic Dermatitis
Reduction in S aureus skin infections may reduce the risk for eczema herpeticum in atopic dermatitisSeptember 15, 2023Atopic Dermatitis
Severe atopic dermatitis raises risks for cardiovascular disease and venous thromboembolismSeptember 15, 2023Atopic Dermatitis
Atopic dermatitis increases the risk for type 2 diabetes mellitus in adultsSeptember 15, 2023Atopic Dermatitis
Tralokinumab is safe and effective in older patients with atopic dermatitisSeptember 15, 2023Atopic Dermatitis
Atopic dermatitis tied to a higher risk for inflammatory bowel disease in children and adultsSeptember 15, 2023Atopic Dermatitis
Dermatology NewsCompany submits supplemental NDA for topical atopic dermatitis treatmentSeptember 12, 2023Atopic DermatitisPediatrics
Dermatology NewsAlmonds and almond oilSeptember 7, 2023Aesthetic DermatologyAtopic DermatitisMixed Topics
Dermatology NewsAtopic dermatitis may be a risk factor for GBS colonization in pregnancyAugust 25, 2023Atopic DermatitisInfectious Diseases
Commentary: Newer Drugs for AD Plus Dupilumab and Other Issues, September 2023August 24, 2023Atopic Dermatitis
Dermatology NewsConsider housing insecurity, other issues when managing challenging skin diseases in children, expert saysAugust 24, 2023PediatricsBusiness of MedicineAtopic Dermatitis
